Given that there is evidence for an MR-NO signaling link in endothelial cells, regulating the MR has the potential to optimize NO conditions and support cardiomyocyte protection during cardiac ischemia/reperfusion (Jia et al., 2016; Victorio et al., 2016). Here, NR3C2 is linked to myocardial ischemia.